journal club presentation first dose in children: physiological insights into pharmacokinetic...

15
JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development Ashley Strougo • Thomas Eissing • Ashraf Yassen • Stefan Willmann • Meindert Danhof • Jan Freijer A.Strougo M. Danhof Division of Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden, NetherlandsA. B.Strougo (&) A. Yassen Global Clinical Pharmacology & Exploratory Development, Astellas Pharma Global Development Europe, Netherlands e-mail: C.T. Eissing S. Willmann Systems Biology & Computational Solutions, Bayer Technology, Germany D. Freijer Centre for Human Drug Research, Leiden, The Netherlands

Upload: theresa-stewart

Post on 16-Jan-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

JOURNAL CLUB PRESENTATION

First dose in children physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development

Ashley Strougo bull Thomas Eissing bull Ashraf Yassen bull Stefan Willmann bull Meindert Danhof bull Jan Freijer

A Strougo 1113088 M Danhof Division of Pharmacology LeidenAmsterdam Center for Drug Research Leiden NetherlandsA

B Strougo (amp) 1113088 A Yassen Global Clinical Pharmacology amp Exploratory Development Astellas Pharma Global Development Europe Netherlands e-mail

C T Eissing 1113088 S Willmann Systems Biology amp Computational Solutions Bayer Technology Germany

D Freijer Centre for Human Drug Research Leiden The Netherlands

Introduction ndash key points

bull Guestimate for first dose in child usually scaled from adult values forndash PKndash PD

bull For PK generally either one of two approaches are usedndash Allometric Scaling +- maturationndash PBPK

Introduction cont

bull Allometric Scaling +- maturationndash Predict Volume of distribution and clearance using

power function derived from theoryndash Maturation function derived from existing PK data

bull PBPK models ndash Mathematical models taking into account

physiological factors such as blood flows organ volumes and partitioning between blood and organs s

AIM

bull Examine interchangeability of AS and PBPK

1 by using two drugs for which PK data in children is abundant -gt Paracetamol and Morphine

2 Hypothetical drugs

Methods

bull Paracetamolndash Glucoronidation (UGT1A6) some sulfation

bull Morphinendash Glucoronidation (UGT2B7)

bull Substantial Differences in Extraction Ratio

Methods ndash Para Morph

bull Using existing model simulate expected popPK in 29 age groups ndash (0 3 7 and 14 days 1 2 3 6 9 months 1 15

and 2 to 18 years in incremental steps of 1 year)ndash Dosing (Morph 10mg IV Paracetamol 1000mg)

bull Calculate AUC using NCA to get CLbull Compare individual quantiles with simulate

quantiles

Methods Cont

bull PBPK clearance predictions compared with PK parameters from studies used to estimate MF

bull Compare AS Maturation functions with maturation function from PBPK

Methods - Hypothetical drugs

bull Generate 108 hypothetical drugsndash Varying combinations of PK properties (see table 1)

bull PK route of elim lipophilicity blood flow protein binding

bull Use PBPK and AS to predict clearancendash 1mg dose IV infusion (30 mins)

Methods - hypotheticals

bull Cl formula

bull AS formula

bull MF formula

Methods

bull Relative prediction interval

bull Graphical Comparison

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 2: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

Introduction ndash key points

bull Guestimate for first dose in child usually scaled from adult values forndash PKndash PD

bull For PK generally either one of two approaches are usedndash Allometric Scaling +- maturationndash PBPK

Introduction cont

bull Allometric Scaling +- maturationndash Predict Volume of distribution and clearance using

power function derived from theoryndash Maturation function derived from existing PK data

bull PBPK models ndash Mathematical models taking into account

physiological factors such as blood flows organ volumes and partitioning between blood and organs s

AIM

bull Examine interchangeability of AS and PBPK

1 by using two drugs for which PK data in children is abundant -gt Paracetamol and Morphine

2 Hypothetical drugs

Methods

bull Paracetamolndash Glucoronidation (UGT1A6) some sulfation

bull Morphinendash Glucoronidation (UGT2B7)

bull Substantial Differences in Extraction Ratio

Methods ndash Para Morph

bull Using existing model simulate expected popPK in 29 age groups ndash (0 3 7 and 14 days 1 2 3 6 9 months 1 15

and 2 to 18 years in incremental steps of 1 year)ndash Dosing (Morph 10mg IV Paracetamol 1000mg)

bull Calculate AUC using NCA to get CLbull Compare individual quantiles with simulate

quantiles

Methods Cont

bull PBPK clearance predictions compared with PK parameters from studies used to estimate MF

bull Compare AS Maturation functions with maturation function from PBPK

Methods - Hypothetical drugs

bull Generate 108 hypothetical drugsndash Varying combinations of PK properties (see table 1)

bull PK route of elim lipophilicity blood flow protein binding

bull Use PBPK and AS to predict clearancendash 1mg dose IV infusion (30 mins)

Methods - hypotheticals

bull Cl formula

bull AS formula

bull MF formula

Methods

bull Relative prediction interval

bull Graphical Comparison

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 3: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

Introduction cont

bull Allometric Scaling +- maturationndash Predict Volume of distribution and clearance using

power function derived from theoryndash Maturation function derived from existing PK data

bull PBPK models ndash Mathematical models taking into account

physiological factors such as blood flows organ volumes and partitioning between blood and organs s

AIM

bull Examine interchangeability of AS and PBPK

1 by using two drugs for which PK data in children is abundant -gt Paracetamol and Morphine

2 Hypothetical drugs

Methods

bull Paracetamolndash Glucoronidation (UGT1A6) some sulfation

bull Morphinendash Glucoronidation (UGT2B7)

bull Substantial Differences in Extraction Ratio

Methods ndash Para Morph

bull Using existing model simulate expected popPK in 29 age groups ndash (0 3 7 and 14 days 1 2 3 6 9 months 1 15

and 2 to 18 years in incremental steps of 1 year)ndash Dosing (Morph 10mg IV Paracetamol 1000mg)

bull Calculate AUC using NCA to get CLbull Compare individual quantiles with simulate

quantiles

Methods Cont

bull PBPK clearance predictions compared with PK parameters from studies used to estimate MF

bull Compare AS Maturation functions with maturation function from PBPK

Methods - Hypothetical drugs

bull Generate 108 hypothetical drugsndash Varying combinations of PK properties (see table 1)

bull PK route of elim lipophilicity blood flow protein binding

bull Use PBPK and AS to predict clearancendash 1mg dose IV infusion (30 mins)

Methods - hypotheticals

bull Cl formula

bull AS formula

bull MF formula

Methods

bull Relative prediction interval

bull Graphical Comparison

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 4: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

AIM

bull Examine interchangeability of AS and PBPK

1 by using two drugs for which PK data in children is abundant -gt Paracetamol and Morphine

2 Hypothetical drugs

Methods

bull Paracetamolndash Glucoronidation (UGT1A6) some sulfation

bull Morphinendash Glucoronidation (UGT2B7)

bull Substantial Differences in Extraction Ratio

Methods ndash Para Morph

bull Using existing model simulate expected popPK in 29 age groups ndash (0 3 7 and 14 days 1 2 3 6 9 months 1 15

and 2 to 18 years in incremental steps of 1 year)ndash Dosing (Morph 10mg IV Paracetamol 1000mg)

bull Calculate AUC using NCA to get CLbull Compare individual quantiles with simulate

quantiles

Methods Cont

bull PBPK clearance predictions compared with PK parameters from studies used to estimate MF

bull Compare AS Maturation functions with maturation function from PBPK

Methods - Hypothetical drugs

bull Generate 108 hypothetical drugsndash Varying combinations of PK properties (see table 1)

bull PK route of elim lipophilicity blood flow protein binding

bull Use PBPK and AS to predict clearancendash 1mg dose IV infusion (30 mins)

Methods - hypotheticals

bull Cl formula

bull AS formula

bull MF formula

Methods

bull Relative prediction interval

bull Graphical Comparison

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 5: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

Methods

bull Paracetamolndash Glucoronidation (UGT1A6) some sulfation

bull Morphinendash Glucoronidation (UGT2B7)

bull Substantial Differences in Extraction Ratio

Methods ndash Para Morph

bull Using existing model simulate expected popPK in 29 age groups ndash (0 3 7 and 14 days 1 2 3 6 9 months 1 15

and 2 to 18 years in incremental steps of 1 year)ndash Dosing (Morph 10mg IV Paracetamol 1000mg)

bull Calculate AUC using NCA to get CLbull Compare individual quantiles with simulate

quantiles

Methods Cont

bull PBPK clearance predictions compared with PK parameters from studies used to estimate MF

bull Compare AS Maturation functions with maturation function from PBPK

Methods - Hypothetical drugs

bull Generate 108 hypothetical drugsndash Varying combinations of PK properties (see table 1)

bull PK route of elim lipophilicity blood flow protein binding

bull Use PBPK and AS to predict clearancendash 1mg dose IV infusion (30 mins)

Methods - hypotheticals

bull Cl formula

bull AS formula

bull MF formula

Methods

bull Relative prediction interval

bull Graphical Comparison

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 6: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

Methods ndash Para Morph

bull Using existing model simulate expected popPK in 29 age groups ndash (0 3 7 and 14 days 1 2 3 6 9 months 1 15

and 2 to 18 years in incremental steps of 1 year)ndash Dosing (Morph 10mg IV Paracetamol 1000mg)

bull Calculate AUC using NCA to get CLbull Compare individual quantiles with simulate

quantiles

Methods Cont

bull PBPK clearance predictions compared with PK parameters from studies used to estimate MF

bull Compare AS Maturation functions with maturation function from PBPK

Methods - Hypothetical drugs

bull Generate 108 hypothetical drugsndash Varying combinations of PK properties (see table 1)

bull PK route of elim lipophilicity blood flow protein binding

bull Use PBPK and AS to predict clearancendash 1mg dose IV infusion (30 mins)

Methods - hypotheticals

bull Cl formula

bull AS formula

bull MF formula

Methods

bull Relative prediction interval

bull Graphical Comparison

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 7: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

Methods Cont

bull PBPK clearance predictions compared with PK parameters from studies used to estimate MF

bull Compare AS Maturation functions with maturation function from PBPK

Methods - Hypothetical drugs

bull Generate 108 hypothetical drugsndash Varying combinations of PK properties (see table 1)

bull PK route of elim lipophilicity blood flow protein binding

bull Use PBPK and AS to predict clearancendash 1mg dose IV infusion (30 mins)

Methods - hypotheticals

bull Cl formula

bull AS formula

bull MF formula

Methods

bull Relative prediction interval

bull Graphical Comparison

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 8: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

Methods - Hypothetical drugs

bull Generate 108 hypothetical drugsndash Varying combinations of PK properties (see table 1)

bull PK route of elim lipophilicity blood flow protein binding

bull Use PBPK and AS to predict clearancendash 1mg dose IV infusion (30 mins)

Methods - hypotheticals

bull Cl formula

bull AS formula

bull MF formula

Methods

bull Relative prediction interval

bull Graphical Comparison

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 9: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

Methods - hypotheticals

bull Cl formula

bull AS formula

bull MF formula

Methods

bull Relative prediction interval

bull Graphical Comparison

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 10: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

Methods

bull Relative prediction interval

bull Graphical Comparison

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 11: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug

Results

  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15
Page 12: JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug
  • JOURNAL CLUB PRESENTATION First dose in children physiologica
  • Introduction ndash key points
  • Introduction cont
  • AIM
  • Methods
  • Methods ndash Para Morph
  • Methods Cont
  • Methods - Hypothetical drugs
  • Methods - hypotheticals
  • Methods
  • Results
  • Slide 12
  • Slide 13
  • Slide 14
  • Slide 15